Exploring Dopamine Transporter Single-photon Emission Computer Tomography Quantification as a Measure of Disease Progression in Idiopathic Parkinson's Disease
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Dec 2019
Price : $35 *
At a glance
- Drugs Ioflupane 123I (Primary)
- Indications Parkinson's disease
- Focus Diagnostic use
- 27 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 27 Nov 2019 Planned End Date changed from 1 Oct 2019 to 1 Sep 2020.
- 27 Nov 2019 Planned primary completion date changed from 1 Oct 2019 to 1 Sep 2020.